US revokes visas of Indian business executives and family members over fentanyl precursor trafficking

The US has revoked and denied visas for certain Indian business executives and their family members over alleged involvement in trafficking fentanyl precursors, according to an official announcement by the US Embassy in New Delhi. This announcement comes as part of the Trump administration’s push to curb synthetic narcotics.

The Embassy stated that the action was taken under sections 221(i), 212(a)(2)(C), and 214(b) of the US Immigration and Nationality Act. Along with visa cancellations, executives linked to companies suspected of trafficking fentanyl precursors will face heightened scrutiny in future visa applications.

“The US Embassy in New Delhi remains steadfast in its commitment to combating illicit drug trafficking. Individuals and organizations involved in the illegal production and trafficking of drugs to the United States, along with their families, will face consequences that may include being denied access to the United States,” said Chargé d’Affaires Jorgan Andrews.

The statement emphasised that stopping the flow of fentanyl and its precursors into the US remains a top priority. It also added cooperation with Indian authorities in tackling the challenge. “Only by working together will our two governments address this transnational threat and keep both our people safe from illicit drugs,” the Embassy said.

The Trump administration has already issued executive orders aimed at securing borders, disrupting drug trafficking networks, and pushing source countries to regulate the movement of precursor chemicals.

The US Mission in India said this move reflects a broader strategy to strengthen drug enforcement while underscoring bilateral cooperation with India.